metformin has been researched along with Parathyroid Neoplasms in 1 studies
Metformin: A biguanide hypoglycemic agent used in the treatment of non-insulin-dependent diabetes mellitus not responding to dietary modification. Metformin improves glycemic control by improving insulin sensitivity and decreasing intestinal absorption of glucose. (From Martindale, The Extra Pharmacopoeia, 30th ed, p289)
metformin : A member of the class of guanidines that is biguanide the carrying two methyl substituents at position 1.
Parathyroid Neoplasms: Tumors or cancer of the PARATHYROID GLANDS.
Excerpt | Relevance | Reference |
---|---|---|
"Less than 10% of parathyroid carcinomas are non-functional, and as such, they have been rarely reported in the literature." | 2.45 | Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery. ( Lewis, JS; Wilkins, BJ, 2009) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Wilkins, BJ | 1 |
Lewis, JS | 1 |
1 review available for metformin and Parathyroid Neoplasms
Article | Year |
---|---|
Non-functional parathyroid carcinoma: a review of the literature and report of a case requiring extensive surgery.
Topics: Amlodipine; Antihypertensive Agents; Deglutition Disorders; Diabetes Mellitus, Type 2; Esophagectomy | 2009 |